on May 8, 2008
Published online before print May 8, 2008, doi: 10.1161/ATVBAHA.108.169078
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on February 14, 2008
Accepted on April 24, 2008
Defective Mer Receptor Tyrosine Kinase Signaling in Bone Marrow Cells Promotes Apoptotic Cell Accumulation and Accelerates Atherosclerosis
Hafid Ait-Oufella ;
From the Institut National de la Santé et de la Recherche Médicale (Inserm), Unit 689 (H.A.-O., V.P., T.S., O.B.-B., K.K., R.M., A.T., Z.M.), Centre de Recherche Cardiovasculaire Lariboisière, Paris, France; Service de Réanimation Médicale (H.A.-O., G.O.), Hôpital Saint-Antoine, Paris, France; Service de Chirurgie Thoracique et Vasculaire (G.L.), Hôpital Bichat, Paris, France; and Philadelphia VA Medical Center (P.L.C.), University of Pennsylvania, Philadelphia.
* To whom correspondence should be addressed. E-mail: mallat{at}larib.inserm.fr.
Objective—To study the role of Mer receptor tyrosine kinase (mertk) in atherosclerosis.
Methods and Results—We irradiated and reconstituted atherosclerosis-susceptible C57Bl/6 low-density lipoprotein receptor–deficient female mice (ldlr-/-) with either a mertk+/+ or mertk-/- (tyrosine kinase-defective mertk) bone marrow. The mice were put on high-fat diet for either 8 or 15 weeks. Mertk deficiency led to increased accumulation of apoptotic cells within the lesions, promoted a proinflammatory immune response, and accelerated lesion development.
Conclusions—Mertk expression by bone marrow–derived cells is required for the disposal of apoptotic cells and controls lesion development and inflammation.
Key words: apoptosis • atherosclerosis • phagocytosis • inflammation
Related Article:
- Macrophage Function and Its Impact on Atherosclerotic Lesion Composition, Progression, and Stability: The Good, the Bad, and the Ugly
- Jeffrey G. Dickhout, Sana Basseri, and Richard C. Austin
Arterioscler Thromb Vasc Biol 2008 28: 1413-1415.[Extract] [Full Text] [PDF]
This article has been cited by other articles:
 |
|
 |
|
  E. Thorp and I. Tabas Mechanisms and consequences of efferocytosis in advanced atherosclerosis J. Leukoc. Biol., November 1, 2009; 86(5): 1089 - 1095. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Seimon and I. Tabas Mechanisms and consequences of macrophage apoptosis in atherosclerosis J. Lipid Res., April 1, 2009; 50(Supplement): S382 - S387. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Mallat, S. Taleb, H. Ait-Oufella, and A. Tedgui The role of adaptive T cell immunity in atherosclerosis J. Lipid Res., April 1, 2009; 50(Supplement): S364 - S369. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. T. Bolick, M. D. Skaflen, L. E. Johnson, S.-C. Kwon, D. Howatt, A. Daugherty, K. S. Ravichandran, and C. C. Hedrick G2A Deficiency in Mice Promotes Macrophage Activation and Atherosclerosis Circ. Res., February 13, 2009; 104(3): 318 - 327. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. C.H. Clarke and M. R. Bennett Cause or Consequence: What Does Macrophage Apoptosis Do in Atherosclerosis? Arterioscler Thromb Vasc Biol, February 1, 2009; 29(2): 153 - 155. [Full Text] [PDF]
|
|
|
|
 |
|
 D. Liao, X. Wang, M. Li, P. H. Lin, Q. Yao, and C. Chen Human protein S inhibits the uptake of AcLDL and expression of SR-A through Mer receptor tyrosine kinase in human macrophages Blood, January 1, 2009; 113(1): 165 - 174. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. G. Dickhout, S. Basseri, and R. C. Austin Macrophage Function and Its Impact on Atherosclerotic Lesion Composition, Progression, and Stability: The Good, the Bad, and the Ugly Arterioscler Thromb Vasc Biol, August 1, 2008; 28(8): 1413 - 1415. [Full Text] [PDF]
|
|